Insider sale notice: R. LaDuane Clifton reports 11,000 shares

R. LaDuane Clifton reported proposed dispositions of Common Stock under a Form 144, including sales disclosed for 02/03/2026 of 11,000 shares and for 01/30/2026 of 3,000 shares.

Rhea-AI Filing Summary

R. LaDuane Clifton reported proposed dispositions of Common Stock under a Form 144, including sales disclosed for 02/03/2026 of 11,000 shares and for 01/30/2026 of 3,000 shares.

The filing lists multiple prior and scheduled issuances or vesting events (restricted stock vesting and previously exercised options) with amounts shown in the excerpt, including a 230,306 share entry for 03/10/2026 and larger vesting entries on 01/31/2025 and 12/31/2025. The filing shows addresses and broker/issuer information for the transactions.

Insights

Securities Attorney

Form 144 notice of proposed sale filed showing discrete recent sales and multiple vested/issuable share items.

The Form 144 excerpt documents two reported sales in the prior three months: 11,000 shares on 02/03/2026 and 3,000 shares on 01/30/2026

The filing also enumerates numerous restricted‑stock vesting entries and a 230,306 share line marked "Previously Exercised Options" dated 03/10/2026. These line items appear as the securities being offered or associated with the reporting person; timing and settlement mechanics are not detailed in the excerpt.

FAQ

What does the Form 144 for ZVRA filed by R. LaDuane Clifton show?

The Form 144 shows proposed dispositions of Common Stock, including 11,000 shares on 02/03/2026 and 3,000 shares on 01/30/2026. It also lists multiple vesting and previously exercised option line items with amounts and dates.

Does the filing list other shares tied to vesting or exercises for ZVRA?

Yes. The excerpt lists several restricted stock vesting entries (example dates: 01/31/2025, 12/31/2025) and a 230,306 share entry labeled "Previously Exercised Options" dated 03/10/2026 as shown in the excerpt.

Who is the broker or intermediary named in the Form 144 excerpt?

The excerpt names Morgan Stanley Smith Barney LLC with an address at 1 New York Plaza, 8th Floor, New York, NY 10004 as the listed broker/executive financial services intermediary in the filing information.

Are the amounts sold in the past three months the same as the larger vesting or exercised amounts listed?

No. The filing separately reports past three‑month sales of 11,000 and 3,000 shares, while other lines list vesting and a 230,306 share previously exercised options entry; the excerpt treats these as distinct line items.

Does the Form 144 specify how sale proceeds will be used or who receives them?

The provided excerpt does not state the use of proceeds or who receives cash from the dispositions. The filing lists the securities, dates, and broker/issuer details but does not disclose proceeds allocation in the excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/16/2026 - 04:45 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001488774
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ZEVRA THERAPEUTICS, INC.
SEC File Number	001-36913
Address of Issuer	101 Federal Street Boston MASSACHUSETTS 02110
Phone	(888) 958-1253
Name of Person for Whose Account the Securities are To Be Sold	RAYMOND L CLIFTON
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	345428	3409374.36	58711584	03/16/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/02/2022	Restricted stock vesting under a registered plan	Issuer			669	06/02/2022	Services Rendered
Common	12/02/2022	Restricted stock vesting under a registered plan	Issuer			533	12/02/2022	Services Rendered
Common	06/02/2023	Restricted stock vesting under a registered plan	Issuer			567	06/02/2023	Services Rendered
Common	11/30/2023	Restricted stock vesting under a registered plan	Issuer			574	11/30/2023	Services Rendered
Common	06/03/2024	Restricted stock vesting under a registered plan	Issuer			586	06/03/2024	Services Rendered
Common	11/29/2024	Restricted stock vesting under a registered plan	Issuer			559	11/29/2024	Services Rendered
Common	01/31/2025	Restricted stock vesting under a registered plan	Issuer			32333	01/31/2025	Services Rendered
Common	05/30/2025	Restricted stock vesting under a registered plan	Issuer			569	05/30/2025	Services Rendered
Common	12/01/2025	Restricted stock vesting under a registered plan	Issuer			578	12/01/2025	Services Rendered
Common	12/31/2025	Restricted stock vesting under a registered plan	Issuer			78154	12/31/2025	Services Rendered
Common	03/10/2026	Previously Exercised Options	Issuer			230306	03/10/2026	Services Rendered

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
R. LaDuane Clifton 101 Federal Street Boston MA 02110	Common	02/03/2026	11000	100774.90
R. LaDuane Clifton 101 Federal Street Boston MA 02110	Common	01/30/2026	3000	26391.30

144: Remarks and Signature

Remarks
Date of Notice	03/16/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Raymond LaDuane Clifton
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)